Welcome to our dedicated page for Core Scientific SEC filings (Ticker: CORZZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking hash-rate growth, electricity contracts, and bitcoin inventory swings inside Core Scientific’s SEC documents can feel like mining through hundreds of pages yourself. Whether you’re hunting for power-purchase liabilities hidden deep in a 10-K or monitoring Core Scientific insider trading Form 4 transactions right before a block-reward halving, the raw filings raise more questions than they answer.
Stock Titan solves that problem. Our AI reads every Core Scientific quarterly earnings report 10-Q filing, flags changes in digital-asset accounting, and delivers plain-English explanations—think Core Scientific SEC filings explained simply. Need real-time alerts? We stream Core Scientific Form 4 insider transactions real-time, connect the dots to market moves, and even highlight hash-rate disclosures inside 8-Ks. From understanding Core Scientific SEC documents with AI to receiving a concise Core Scientific earnings report filing analysis, you get clarity without sifting through technical jargon.
Every filing type is covered: a Core Scientific annual report 10-K simplified so you can compare energy-efficiency metrics; an easy-to-scan table inside the Core Scientific proxy statement executive compensation for stock-based awards; instant notification when a new Core Scientific 8-K material events explained mentions power-grid curtailment. Professional use cases include spotting Core Scientific executive stock transactions Form 4 before financing rounds, evaluating quarter-over-quarter mining margin trends, and verifying hosting revenue growth. All data updates the moment EDGAR posts, and AI-powered summaries turn complex crypto disclosures into the insights you need to make informed decisions.
Reporting persons G1 Execution Services, LLC; SIG Brokerage, LP; Susquehanna Investment Group; and Susquehanna Securities, LLC disclose an aggregate beneficial ownership of 18,336,176 shares of Core Scientific, Inc. common stock, representing 6.2% of the class based on the company’s reported 297,821,835 shares outstanding. The reported position includes direct holdings and securities exercisable or convertible into shares, including options and warrants.
The filing states these affiliated broker-dealers may be deemed a group and reports both sole and shared voting and dispositive power across the reporting persons. The reporting persons certify the holdings are held in the ordinary course of business and not for the purpose of changing control. Investors should note that part of the position derives from options, warrants or convertible instruments and therefore may reflect potential dilution rather than current free-floating shares.
Core Scientific reported a large headline net loss driven primarily by non-cash changes in derivative valuations, while its operating business shows mixed trends. Cash and cash equivalents declined to $581.3 million from $836.2 million, but the company materially increased its bitcoin holdings to 1,612 BTC with a fair value of $172.8 million. Total assets rose to $1.978 billion and property, plant and equipment, net increased to $828.6 million, reflecting ongoing capital investment.
Revenue fell versus prior year to $78.6 million for the quarter, producing a small gross profit but operating losses as selling, general and administrative costs rose. Large non-operating items included a $923.5 million increase in the fair value of Tranche 2 warrants recorded as expense, producing a three-month net loss of $936.8 million. Warrant liabilities total $1.3167 billion, convertible debt remains significant, and contractual capital commitments total approximately $1.71 billion. The company disclosed the proposed acquisition by CoreWeave and detailed related transaction risks.
Core Scientific, Inc. furnished a press release announcing its financial results for the second fiscal quarter ended June 30, 2025. The press release is provided as Exhibit 99.1 to this Current Report and is incorporated by reference into Items 2.02 and 7.01 of the filing. The company states that the information in Items 2.02 and 7.01, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference in Securities Act filings.
The 8-K itself does not include the underlying financial metrics or operational detail; readers must review Exhibit 99.1 for the actual results. The filing also lists the registrant's exchange-listed securities: common stock CORZ and warrants CORZW and CORZZ.
Two Seas Capital LP, together with its general partner and CIO Sina Toussi, filed a Schedule 13D disclosing beneficial ownership of 19,122,842 Core Scientific (CORZZ) shares, or 6.3 % of the outstanding common stock. The position is held across the firm’s Strategic Fund, Global Fund and two managed accounts and includes 5.72 m options and 313.6 k warrants. Aggregate consideration for the shares, options and warrants totals roughly $133.9 million, funded with the working capital of the funds/accounts.
The filing signals an activist stance: on 7 Aug 2025 Two Seas issued an open letter stating it will vote against the proposed merger between Core Scientific and CoreWeave and intends to solicit proxies opposing the deal at the forthcoming special meeting. The filer may engage management and other shareholders, and could adjust its exposure through additional purchases, sales or hedging transactions—including swaps that reference a notional 500 k shares—depending on market conditions and strategic considerations.
FAQ
What is the current stock price of Core Scientific (CORZZ)?
